You are viewing the site in preview mode
Skip to main content
|
CV risk factor
|
Treatment
|
Responders with reported risk factor reporting receiving treatment
|
p
|
|---|
| |
RA
|
PsA
| |
|---|
| |
N (%)
|
N (%)
| |
|---|
|
Hypertension
|
Pharmacological
|
259/279 (92.8)
|
50/53 (94.3)
|
0.7
|
|
Diabetes
|
Diet and/or pharmacological
|
73/73 (100.0)
|
14/14 (100.0)
|
N/A
|
|
Hyperlipidaemia
|
Pharmacological
|
109/157 (69.4)
|
19/26 (73.1)
|
0.7
|
|
Overweight or obese
|
Any dietary change in the last year
|
151/564 (26.8)
|
36/131 (27.5)
|
0.9
|
|
Commercial weight loss program
|
21/564 (3.7)
|
3/131 (2.3)
|
0.4
|
|
Health professional weight loss program
|
44/564 (7.8)
|
7/131 (5.3)
|
0.3
|
|
Meal replacements
|
53/564 (9.4)
|
10/131 (7.6)
|
0.5
|
|
Exercise program
|
57/564 (10.1)
|
11/131 (8.4)
|
0.6
|
|
Bariatric surgery
|
4/564 (0.7)
|
1/131 (0.8)
|
0.9
|
- Treatment for hypertension, diabetes, hyperlipidaemia and being overweight or obese in RA and PsA respondents to the Heart Survey and a comparison of the two disease groups
- CV cardiovascular, RA rheumatoid arthritis, PsA psoriatic arthritis, N/A not applicable
